Hôpital Lapeyronie; Immuno-Rhumatologie Pr Jorgensen
Montpellier, France
Rheumatologist in Montpellier
191 Av. du Doyen Gaston Giraud, 34090 Montpellier
About Hôpital Lapeyronie; Immuno-Rhumatologie Pr Jorgensen
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hôpital Lapeyronie; Immuno-Rhumatologie Pr Jorgensen
During the past decade, Hôpital Lapeyronie; Immuno-Rhumatologie Pr Jorgensen conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes Mellitus
2015-05-14
2017-03-27
Completed
275
Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus
2015-05-12
2017-06-16
Completed
880
Long-term Safety and Efficacy of Empagliflozin as Add on to GLP-1 RA
2015-10-29
2017-06-02
Completed
65
A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
2019-05-07
2021-03-31
Completed
636
Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19)
2020-11-23
2022-02-01
Completed
500
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight
2021-03-29
2023-04-10
Completed
938
A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity
2021-01-29
2023-10-17
Active, not recruiting
627
A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
2021-04-13
2023-04-29
Active, not recruiting
585
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hôpital Lapeyronie; Immuno-Rhumatologie Pr Jorgensen
According to Clinical.Site data, the most researched conditions in "Hôpital Lapeyronie; Immuno-Rhumatologie Pr Jorgensen" are
"Juvenile Idiopathic Arthritis" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Hôpital Lapeyronie; Immuno-Rhumatologie Pr Jorgensen" in a lesser frequency.
Clinical Trials Intervention Types at Hôpital Lapeyronie; Immuno-Rhumatologie Pr Jorgensen
Most popular intervention types in "Hôpital Lapeyronie; Immuno-Rhumatologie Pr Jorgensen" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Tocilizumab" (2 trials), "Methotrexate" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hôpital Lapeyronie; Immuno-Rhumatologie Pr Jorgensen
The vast majority of trials in "Hôpital Lapeyronie; Immuno-Rhumatologie Pr Jorgensen" are
2 trials for "All" genders.
Clinical Trials Status at Hôpital Lapeyronie; Immuno-Rhumatologie Pr Jorgensen
Currently, there are NaN active trials in "Hôpital Lapeyronie; Immuno-Rhumatologie Pr Jorgensen".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Hôpital Lapeyronie; Immuno-Rhumatologie Pr Jorgensen,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hôpital Lapeyronie; Immuno-Rhumatologie Pr Jorgensen, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".